One cell in one billion: the new Italian technology for attacking cancer
September 11, 2013
Florence - Real hope in identifying new tools in the fight against cancer. Menarini has completed its acquisition of Silicon Biosystems which has patented DEPArray ™, the first technology of its kind that is able to automatically isolate rare single cancer cells in blood while keeping them intact, alive and capable of reproducing themselves by [...]
September 11, 2013
Mountain View, CA — Genia Technologies, Inc. today announced that the company, as part of a research consortium with Columbia University and Harvard Medical School, received a Revolutionary Genome Sequencing Technologies – The $1,000 Genome grant from the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH). The grant – $5.25 [...]
September 11, 2013
BILLERICA, Mass — RainDance Technologies, Inc., the Digital Biology™ Company, announced a publication demonstrating the use of the company’s digital PCR technology for detecting mutations in circulating tumor DNA directly from blood samples. The paper, co-authored by a consortium of research clinicians in France and RainDance scientists, highlights the significant value unlocked by the company’s [...]
Genomatix Pathway System (GePS) now available in Illumina’s BaseSpace Apps.
September 11, 2013
Munich, Germany - Genomatix today announced it has added the Genomatix Pathway System (GePS) to BaseSpace Apps, Illumina’s dedicated applications store and informatics community dedicated to advancing genomic analysis. Using GePS, researchers can generate and visualize genetic networks and pathways and easily access a multitude of data on the genes and gene-gene connections they consist [...]
Hitachi High-Technologies Launches New UHPLC System, ChromasterUltra Rs
September 11, 2013
Hitachi High-Technologies Corporation (TOKYO: 8036, Hitachi High-Tech) today announced the global launch of ChromasterUltra Rs, a new Ultra High Performance Liquid Chromatography (UHPLC) system that achieves enhanced ultra high speed, high resolution and high sensitivity analysis. UHPLC systems are analytical tools for performing highly accurate qualitative and quantitative measurements of the composition, concentration and other [...]
908 Devices Receives $7 Million in Series B Funding and Signs Multi-Year Development Agreement
September 11, 2013
Boston, MA: 908 Devices, an innovator in point-of-need chemical analysis, today announced that it received $7M in Series B funding, which included new investment from Schlumberger and follow-on investments from ARCH Venture Partners, Razor’s Edge Ventures and University of Tokyo Edge Capital (UTEC). In addition, 908 Devices and Schlumberger signed a technical collaboration and development [...]
September 10, 2013
Hitachi High-Tech Science Corporation announces the development and worldwide release of the EA1000VX on September 10th, 2013. The improved X-ray analyzer enables fast and simple screening of hazardous substances (regulated by European Union directives such as ELV, WEEE, and RoHS) in automobiles and electrical/electronic devices. Shorter inspection time and better operability have been demanded for [...]
Solulink Appoints Life Science Industry Veteran Jack Ball as Chief Executive Officer
September 10, 2013
SAN DIEGO, Sept. -- Solulink, Inc., an emerging life science tools company with expertise in biomolecular linking, announced today that Jack Ball has been appointed as the company's Chief Executive Officer. A proven performer, Mr. Ball will lead the company as it commercializes its HybriLink™ technology. The HybriLink technology solves the 'missing color' problem: the [...]
HEPREGEN LAUNCHES FIRST RAT HEPATOPACTM DMPK ASSAY KITS FOR METABOLITE IDENTIFICATION AND PROFILING
September 10, 2013
MEDFORD, MA -- Hepregen Corporation, leader in the development of next generation HepatoPac(TM) and HepatoMune(TM) cell-based assay products, announced today the commercial launch of the Company's first application-oriented Rat HepatoPac(TM) kits designed specifically for use in metabolite identification and profiling. A kit may be ordered that contains either Wistar-Hahn or Sprague-Dawley rat hepatocytes. Much like [...]
September 10, 2013
Austin, Texas and Auckland, New Zealand - Emergent Technologies, Inc. a leading innovation solutions company and KODE Biotech, Ltd, developer of the revolutionary KODE™ biosurface modification technology, have entered into a commercialization agreement in which Emergent will be KODE Biotech’s agent for technology commercialization. The agreement provides for revenue sharing between Emergent and KODE Biotech [...]

